Published in Johns Hopkins Med J on September 01, 1975
Hemoglobin F synthesis in vitro: evidence for control at the level of primitive erythroid stem cells. Proc Natl Acad Sci U S A (1977) 2.43
Stimulation of fetal hemoglobin synthesis in bone marrow cultures from adult individuals. Proc Natl Acad Sci U S A (1976) 1.66
Inheritance of F cell frequency in heterocellular hereditary persistence of fetal hemoglobin: an example of allelic exclusion. Am J Hum Genet (1977) 1.06
Proportion of fetal hemoglobin synthesis decreases during erythroid cell maturation. Proc Natl Acad Sci U S A (1980) 0.91
Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci U S A (1977) 13.87
Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med (2000) 5.43
Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) (1977) 3.20
Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med (1972) 2.79
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol (1988) 2.60
Exploratory and confirmatory tests of the big five and Tellegen's three- and four-dimensional models. J Pers Soc Psychol (1994) 2.56
Therapeutic defibrination in the treatment of thrombotic disease. Lancet (1968) 2.40
The nephrotic syndrome associated with secondary syphilis. An immune deposit disease. Am J Med (1970) 2.37
SV40 recombinants carrying rabbit beta-globin gene coding sequences. Cell (1979) 2.35
Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse. Blood (1998) 2.31
Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med (1988) 2.19
Human Y-chromosome-specific reiterated DNA. Science (1976) 2.02
Cytidine deaminase and the development of resistance to arabinosyl cytosine. Nat New Biol (1971) 1.97
A comparative analysis of pulmonary perfusion scans with pulmonary angiograms. Am Heart J (1976) 1.93
Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine (Baltimore) (1981) 1.88
Fetal hemoglobin restriction to a few erythrocytes (F cells) in normal human adults. Science (1975) 1.85
Alkaline Phosphatase in Human Sera and Placentae: Starch gel electrophoresis reveals many phosphatase components including a polymorphism in placentae. Science (1961) 1.84
Current concepts: guidelines for the use of thrombolytic agents. N Engl J Med (1979) 1.82
Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1987) 1.82
Hemoglobin biosynthesis in murine virus-induced leukemic cells in vitro: structure and amounts of globin chains produced. Blood (1972) 1.81
Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol (1978) 1.79
The clinical features of submassive and massive pulmonary emboli. Am J Med (1977) 1.77
Ophthalmic manifestations of leukemia. Arch Ophthalmol (1989) 1.75
Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia. Am J Med (1986) 1.64
Letter: Dilantin, agranulocytosis, and phagocytic marrow histiocytes. Ann Intern Med (1976) 1.63
Individual variation in the production and survival of F cells in sickle-cell disease. N Engl J Med (1978) 1.59
Disseminated intravascular coagulation and portal hypertension following pancreatic islet autotransplantation. Ann Surg (1980) 1.58
Typhoid fever. Studies of blood coagulation, bacteremia, and endotoxemia. Arch Intern Med (1978) 1.52
F-cell production in sickle cell anemia: regulation by genes linked to beta-hemoglobin locus. Science (1981) 1.51
Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients. Ann Intern Med (1976) 1.46
Leukemic retinopathy. Relationship between fundus lesions and hematologic parameters at diagnosis. Ophthalmology (1989) 1.46
Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10) Br J Haematol (1990) 1.45
Oxidative damage in age-related macular degeneration. Histol Histopathol (2007) 1.44
Intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor causes a cutaneous eruption. Arch Dermatol (1991) 1.44
Acetaminophen and warfarin: undesirable synergy. JAMA (1998) 1.43
A phase II "window" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia. Clin Cancer Res (1998) 1.42
Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrow. Pharmacogenomics J (2003) 1.41
Isolation of a rat liver delta-aminolevulinate dehydrase (ALAD) cDNA clone: evidence for unequal ALAD gene dosage among inbred mouse strains. Proc Natl Acad Sci U S A (1986) 1.40
Hypermethylation of the 5' region of the calcitonin gene is a property of human lymphoid and acute myeloid malignancies. Blood (1987) 1.39
The effect of arvin on blood coagulation factors. Br J Haematol (1968) 1.39
Trousseau's syndrome. Devastating coagulopathy in the absence of heparin. Am J Med (1985) 1.38
Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. N Engl J Med (1986) 1.35
Current status of pulmonary thromboembolic disease: pathophysiology, diagnosis, prevention, and treatment. Am Heart J (1982) 1.34
Electrophoretic and functional heterogeneity of pepsinogen in several species. Nature (1966) 1.34
Binding and endocytosis of cluster glycosides by rabbit hepatocytes. Evidence for a short-circuit pathway that does not lead to degradation. J Biol Chem (1982) 1.32
Phase I and pharmacodynamic study of taxol in refractory acute leukemias. Cancer Res (1989) 1.31
In vitro cytotoxic activity of Thai medicinal plants used traditionally to treat cancer. J Ethnopharmacol (2004) 1.27
Increased nerve-growth-factor beta-chain cross-reacting material in familial dysautonomia. N Engl J Med (1976) 1.23
Disorganization of cultured vascular endothelial cell monolayers by fibrinogen fragment D. Science (1985) 1.19
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo. Br J Cancer (2006) 1.19
Nucleotide sequence of rat liver delta-aminolevulinic acid dehydratase cDNA. Nucleic Acids Res (1986) 1.19
Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy. Cancer Res (2000) 1.18
Acyclovir prophylaxis against herpes simplex virus infection in patients with leukemia. A randomized, double-blind, placebo-controlled study. Ann Intern Med (1983) 1.18
Abnormal methylation of the calcitonin gene marks progression of chronic myelogenous leukemia. Blood (1991) 1.17
Localization of a fibrinogen calcium binding site between gamma-subunit positions 311 and 336 by terbium fluorescence. J Biol Chem (1985) 1.16
The heart and cardiac conduction system in thrombotic thrombocytopenic purpura. A clinicopathologic study of 17 autopsied patients. Ann Intern Med (1979) 1.16
Microscopic method for assaying F cell production: illustrative changes during infancy and in aplastic anemia. Blood (1978) 1.15
Quantitation of hemoglobins within individual red cells: asynchronous biosynthesis of fetal and adult hemoglobin during erythroid maturation in normal subjects. Blood (1980) 1.15
Differences in the infrared stretching frequency of carbon monoxide bound to abnormal hemoglobins. Biochemistry (1969) 1.15
Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med (1986) 1.14
Linkage Between the X Chromosome Loci for Glucose-6-Phosphate Dehydrogenase Electrophoretic Variation and Hemophilia A. Am J Hum Genet (1965) 1.14
Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia. Blood (1994) 1.14
Hemoglobin 3 chains in apes. Primary structures and the presumptive nature of back mutation in a normally silent gene. J Biol Chem (1973) 1.12
Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J Biol Chem (1988) 1.12
A two-step timed sequential treatment for acute myelocytic leukemia. Blood (1989) 1.11
Differences in the amino acid sequences of tryptic peptides from three sheep hemoglobin beta chains. J Biol Chem (1967) 1.10
Formaldehyde in human cancer cells: detection by preconcentration-chemical ionization mass spectrometry. Anal Chem (2001) 1.10
Evaluation of the Microbial Identification System for identification of clinically isolated yeasts. J Clin Microbiol (1996) 1.08
Production of erythrocytes that contain fetal hemoglobin in anemia. Transient in vivo changes. J Clin Invest (1979) 1.07
Carbohydrate structure of human fibrinogen. Use of 300-MHz 1H-NMR to characterize glycosidase-treated glycopeptides. J Biol Chem (1982) 1.07
Inheritance of F cell frequency in heterocellular hereditary persistence of fetal hemoglobin: an example of allelic exclusion. Am J Hum Genet (1977) 1.06
Disseminated intravascular coagulation. Johns Hopkins Med J (1980) 1.06
Cytotoxic antibody in normal human serums reactive with tumor cells from acute lymphocytic leukemia. Science (1972) 1.05
Erythropoietin receptors on murine erythroid colony-forming units: natural history. Blood (1989) 1.05
Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia. J Clin Oncol (1994) 1.04
Hemoglobins A and A2 in New World primates: comparative variation and its evolutionary implications. Science (1969) 1.02
Marrow transplanation in man following cyclophosphamide. Transplant Proc (1971) 1.01
Disseminated intravascular coagulation during heparin therapy. Ann Intern Med (1974) 1.01
Specific inhibition of formation of transcription complexes by a calicheamicin oligosaccharide: a paradigm for the development of transcriptional antagonists. Proc Natl Acad Sci U S A (1994) 1.01
Two-cycle timed-sequential chemotherapy for adult acute nonlymphocytic leukemia. Blood (1984) 1.01
Organization and heterogeneity of sequences within a repeating unit of human Y chromosome deoxyribonucleic acid. Biochemistry (1979) 1.01
Cimetidine potentiation of the hypoprothrombinemic effect of warfarin. Ann Intern Med (1979) 1.00
Microwave transport in metallic single-walled carbon nanotubes. Nano Lett (2005) 1.00
Pseudothrombocytopenia: manifestation of a new type of platelet agglutinin. Blood (1973) 1.00
Fibrinogen sialic acid residues are low affinity calcium-binding sites that influence fibrin assembly. J Biol Chem (1989) 1.00
Microwave technology for the rapid thawing of frozen blood components. Am J Clin Pathol (1985) 1.00
Timed sequential therapy of human leukemia based upon the response of leukemic cells to humoral growth factors. Cancer Res (1977) 0.99
Cloning and sequence of mouse erythroid delta-aminolevulinate dehydratase cDNA. Nucleic Acids Res (1989) 0.99
Ablation of human choriocarcinoma xenografts in nude mice by antibody-directed enzyme prodrug therapy (ADEPT) with three novel compounds. Eur J Cancer (1991) 0.99